II
LXRX icon

Ishara Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ishara Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
1,271,000
+369,000
+41% +$719K 2.24% 17
2026
Q1 		$1.41M Buy
902,000
+22,000
+3% +$32K 1.33% 29
2025
Q4 		$1.01M Buy
+880,000
New +$1.21M 1.16% 30

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ishara Investments's LXRX Position: Q2 2026 in Review

Ishara Investments increased its Lexicon Pharmaceuticals (LXRX) stake by 41% in Q2 2026, buying an estimated $719K and bringing the position to 1,271,000 shares worth $3.05M. The position accounts for 2.24% of the portfolio, ranked #17.

Ishara Investments first reported a position in LXRX in Q4 2025 and has held it in 3 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Ishara Investments held 1,271,000 shares of Lexicon Pharmaceuticals worth $3.05M as of Q2 2026.
  • Ishara Investments bought 369,000 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $719K.
  • Lexicon Pharmaceuticals made up 2.24% of Ishara Investments's portfolio in Q2 2026, its #17 holding.
  • Ishara Investments first reported a position in Lexicon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.